Security key
22407B108
Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (COYA)
CUSIP: 22407B108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 3,268,292
- Total 13F value
- $19,805,900
- Share change
- -70,768
- SEC-reported price per share
- $6.06
- Number of holders
- 19
- Value change
- -$932,467
- Number of buys
- 9
- Number of sells
- 10
- Shares outstanding
- 23,172,091
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
19
Top holders
10
COYA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Coya Therapeutics, Inc. SEC filings
Coya Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22407B108
Recent filing periods:
Ownership snapshot
Top reported holders of COYA - Coya Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
DME Capital Management, LP
Disclosed value leader
DME Capital Management, LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 5.5%
Showing 1-6 of 15 holder rows.
Quick read
DME Capital Management, LP leads the comparable SEC ownership view at 5.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens DME Capital Management, LP's linked filing trail.
Comparable ownership
Top 5
DME Capital Management, LP
5.5%
VANGUARD GROUP INC
3.7%
AIGH Capital Management LLC
2.8%
GEODE CAPITAL MANAGEMENT, LLC
0.54%
RAYMOND JAMES & ASSOCIATES
0.48%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| DME Capital Management, LP |
13F
Company
|
5.5%
|
$12,638,338
1,274,026 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.7%
|
$8,407,101
847,490 shares
|
— | 31 Mar 2024 |
| AIGH Capital Management LLC |
13F
Company
|
2.8%
|
$6,442,315
649,427 shares
|
— | 31 Mar 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.54%
|
$1,250,098
125,996 shares
|
— | 31 Mar 2024 |
| RAYMOND JAMES & ASSOCIATES |
13F
Company
|
0.48%
|
$1,092,142
110,095 shares
|
— | 31 Mar 2024 |
| CM Management, LLC |
13F
Company
|
0.43%
|
$992,000
100,000 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
3,268,292
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
58
Q2 2024 holders
19
Holder diff
-39
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend